Health economic evaluation: A primer for the practicing rheumatologist
作者： Michael C. Y. Tan , Dean A. Regier , John M. Esdaile , Larry D. Lynd , Aslam H. Anis
DOI: 10.1002/ART.22105
关键词:
摘要:
sci-hub.se 参考文章(55)
Milton C. Weinstein, Clinical Decision Analysis ,(1980)
Paco M. J. Welsing, Johan L. Severens, Margriet Hartman, Piet L. C. M. van Riel, Roland F. J. M. Laan, Modeling the 5-year cost effectiveness of treatment strategies including tumor necrosis factor-blocking agents and leflunomide for treating rheumatoid arthritis in the Netherlands. Arthritis & Rheumatism. ,vol. 51, pp. 964- 973 ,(2004) , 10.1002/ART.20843
Aslam H Anis, John M Esdaile, Carlo A Marra, Practical pharmacogenetics: the cost effectiveness of screening for thiopurine s-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine. The Journal of Rheumatology. ,vol. 29, pp. 2507- 2512 ,(2002)
Marjorie E Ginsburg, Richard L Kravitz, William A Sandberg, A survey of physician attitudes and practices concerning cost-effectiveness in patient care Western Journal of Medicine. ,vol. 173, pp. 390- 394 ,(2000) , 10.1136/EWJM.173.6.390
Andrew Moore, Ceri Phillips, Elke Hunsche, James Pellissier, Simone Crespi, Economic Evaluation of Etoricoxib versus Non-Selective NSAIDs in the Treatment of Osteoarthritis and Rheumatoid Arthritis Patients in the UK PharmacoEconomics. ,vol. 22, pp. 643- 660 ,(2004) , 10.2165/00019053-200422100-00003
Jeffrey S. Hoch, Andrew H. Briggs, Andrew R. Willan, Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis. Health Economics. ,vol. 11, pp. 415- 430 ,(2002) , 10.1002/HEC.678
Carlo A. Marra, John C. Woolcott, Jacek A. Kopec, Kamran Shojania, Robert Offer, John E. Brazier, John M. Esdaile, Aslam H. Anis, A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis Social Science & Medicine. ,vol. 60, pp. 1571- 1582 ,(2005) , 10.1016/J.SOCSCIMED.2004.08.034
Robert J Tibshirani, Bradley Efron, An introduction to the bootstrap ,(1993)
James M Pellissier, Douglas J Watson, Sheldon X Kong, Walter L Straus, None, Cost-Effectiveness of Cyclooxygenase-2 Inhibitors in Chronic Arthritis Annals of Internal Medicine. ,vol. 140, pp. 761- 761 ,(2004) , 10.7326/0003-4819-140-9-200405040-00019
Paul Moayyedi, James Mason, Cost-utility and cost-benefit analyses: how did we get here and where are we going? European Journal of Gastroenterology & Hepatology. ,vol. 16, pp. 527- 534 ,(2004) , 10.1097/00042737-200406000-00004